Title {1}	INTEnsive care bundle with blood pressure Reduction in Acute Cerebral Hemorrhage trial (INTERACT3): study protocol for a pragmatic stepped-wedge cluster-randomized controlled trial
Trial registration {2a and 2b}	ClinicalTrials.gov identifier: NCT03209258. Chinese Trial Registry identifier ChiCTR-IOC-17011787.
Protocol version {3}	Version 3.0 – 12 August 2019
Funding {4}	MRC Joint Global Health Trials Call 9 (MR/T005009/1), National Health and Medical Research Council (NHMRC) of Australia (APP1149987), the West China Hospital Outstanding Discipline Development 1-3-5 Program (ZY2016102), and Sichuan Credit Pharmaceutical Co., Ltd, and Takeda (China) International Trading Co., Ltd
Author details {5a}	1The George Institute China, Peking University Health Science Center, China 2The George Institute for Global Health, Faculty of Medicine, UNSW, Australia 3West China Hospital, Sichuan University, China 4Faculty of Medicine Clínica Alemana Universidad del Desarrollo, Chile 5National Institute of Neurological Sciences, Peru 6University of São Paulo, Brazil 7Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez, Mexico 8The Aga Khan University, Pakistan 9University of Kelaniya, Colombo, Sri Lanka 10115 Hospital, Vietnam 11Chiristian Medical College and Hospital, India 12University of Ilorin & University of Ilorin Teaching Hospital, Nigeria 13University of Sydney, Australia 14Royal Prince Alfred Hospital, Australia
Name and contact information for the trial sponsor {5b}	The George Institute for Global Health (Australia) Beijing Representative Office, Room 011, Unit 2, Tayuan Diplomatic Office Building, No. 14 Liangmahe Nan Lu, Chaoyang District, Beijing, China. Phone: + 86 10 8280 0577; Fax: +86 10 8280 0177; Email: interact3@georgeinstitute.org.cn
Role of sponsor and funder {5c}	The study sponsors and funders had no role in the design, execution, analyses, interpretation of data, or decision to submit results for this study